IntriCon (NASDAQ:IIN) updated its FY 2021 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $- for the period. The company issued revenue guidance of $119 million-123 million, compared to the consensus revenue estimate of $117.35 million.
A number of research firms have recently issued reports on IIN. Zacks Investment Research downgraded shares of IntriCon from a buy rating to a hold rating in a research note on Thursday, May 13th. B. Riley restated a buy rating and set a $32.00 target price (up from $28.00) on shares of IntriCon in a report on Friday, February 26th.
Shares of NASDAQ IIN traded up $0.10 during mid-day trading on Friday, hitting $21.93. The company had a trading volume of 587 shares, compared to its average volume of 43,906. IntriCon has a 1-year low of $9.95 and a 1-year high of $28.16. The stock has a market cap of $198.95 million, a P/E ratio of -545.75, a PEG ratio of 3.52 and a beta of 1.31. The business’s 50-day moving average price is $23.70.
In related news, VP Dennis Gonsior sold 22,852 shares of the company’s stock in a transaction dated Thursday, April 1st. The stock was sold at an average price of $24.47, for a total value of $559,188.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 10.80% of the company’s stock.
IntriCon Company Profile
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets.
Further Reading: What is a CD ladder?
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.